Imatinib and tyrosine kinase inhibition, in the management of BCR-ABL negative myeloproliferative disorders

di Mesa, Ruben A
Pubblicazione 2007

The evolving treatment paradigm in myelofibrosis

di Mesa, Ruben A.
Pubblicazione 2013

Letter to Our Readers

di Mesa, Ruben A.
Pubblicato in Am Health Drug Benefits (2014)

NCCN Debuts New Guidelines for Myeloproliferative Neoplasms

di Mesa, Ruben A.
Pubblicato in J Natl Compr Canc Netw (2017)

New Guidelines From the NCCN for Polycythemia Vera

di Mesa, Ruben A.
Pubblicato in Clin Adv Hematol Oncol (2017)

Refining the Management of Polycythemia Vera

di Mesa, Ruben A.
Pubblicato in Clin Adv Hematol Oncol (2018)

Targeting hedgehog signaling in myelofibrosis and other hematologic malignancies

di Tibes, Raoul, Mesa, Ruben A
Pubblicazione 2014

Optimizing management of ruxolitinib in patients with myelofibrosis: the need for individualized dosing

di Mesa, Ruben A, Cortes, Jorge
Pubblicato in J Hematol Oncol (2013)

Myeloproliferative Neoplasms: Translating New Discoveries Into Better Outcomes, Better Quality of Life

di Padrnos, Leslie, Mesa, Ruben A.
Pubblicato in Oncology (Williston Park) (2017)

Approach to MPN Symptom Assessment

di Geyer, Holly, Mesa, Ruben A.
Pubblicato in Curr Hematol Malig Rep (2017)

Profile of pomalidomide and its potential in the treatment of myelofibrosis

di Gowin, Krisstina L, Mesa, Ruben A
Pubblicato in Ther Clin Risk Manag (2015)

Managing myelofibrosis (MF) that “blasts” through: advancements in the treatment of relapsed/refractory and blast-phase MF

di Scherber, Robyn M., Mesa, Ruben A.
Pubblicato in Hematology Am Soc Hematol Educ Program (2018)

Pacritinib and its use in the treatment of patients with myelofibrosis who have thrombocytopenia

di Diaz, Adolfo Enrique, Mesa, Ruben A
Pubblicato in Future Oncol (2018)

Management of myelofibrosis after ruxolitinib failure

di Harrison, Claire N, Schaap, Nicolaas, Mesa, Ruben A
Pubblicato in Ann Hematol (2020)

Allogeneic Stem Cell Transplantation in Myelofibrosis

di Jain, Tania, Mesa, Ruben A., Palmer, Jeanne M.
Pubblicato in Biol Blood Marrow Transplant (2017)

Analysis of the Use and Impact of Twitter During American Society of Clinical Oncology Annual Meetings From 2011 to 2016: Focus on Advanced Metrics and User Trends

di Pemmaraju, Naveen, Thompson, Michael A., Mesa, Ruben A., Desai, Tejas
Pubblicato in J Oncol Pract (2017)

The use and impact of Twitter at medical conferences: Best practices and Twitter etiquette

di Pemmaraju, Naveen, Mesa, Ruben A., Majhail, Navneet S., Thompson, Michael A.
Pubblicato in Semin Hematol (2017)

The Need for United States–Based Guidelines for Myeloproliferative Neoplasms

di Stein, Brady L., O’Brien, Susan, Greenberg, Peter, Mesa, Ruben A.
Pubblicato in J Natl Compr Canc Netw (2015)

Impact of Inflammation on Myeloproliferative Neoplasm Symptom Development

di Geyer, Holly L., Dueck, Amylou C., Scherber, Robyn M., Mesa, Ruben A.
Pubblicato in Mediators Inflamm (2015)

Quality of life and symptom burden among myeloproliferative neoplasm patients: Do symptoms impact quality of life?

di Langlais, Blake T, Geyer, Holly, Scherber, Robyn, Mesa, Ruben A, Dueck, Amylou C
Pubblicato in Leuk Lymphoma (2018)